China Health Industries Holdings, Inc. (CHHE)
- Previous Close
0.2924 - Open
0.3924 - Bid --
- Ask --
- Day's Range
0.2924 - 0.2924 - 52 Week Range
0.1000 - 4.1500 - Volume
200 - Avg. Volume
25 - Market Cap (intraday)
19.164M - Beta (5Y Monthly) -20.47
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds. It also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand. In addition, the company offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements. Further, it manufactures and sells various types of medical drugs, such as enema glycerini, umguentumacidi borici camphoratum, ge hong beriberi water, pelvic inflammation suppository, injury and paralysis tincture, indometacin and furazolidone suppositories, injury and rheumatism relieving paste, refining goupi cream, muskiness pain relieving paste, muskiness bone strengthener paste, matrine suppositories, ethacriding lactate solution, iodine tincture, mercurochrome solution, hydrogen peroxide solution, halcinonide cream, compound fluocinonide tincture, and policresulen vaginal suppository. The company primarily sells its products through sales personnel and sales agents. China Health Industries Holdings, Inc. was founded in 1996 and is based in Harbin City, the People's Republic of China.
www.chinahealthindustries.com32
Full Time Employees
June 30
Fiscal Year Ends
Sector
Related News
Performance Overview: CHHE
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHHE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHHE
Valuation Measures
Market Cap
19.16M
Enterprise Value
24.80M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
163.41
Price/Book (mrq)
0.66
Enterprise Value/Revenue
211.47
Enterprise Value/EBITDA
-10.22
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-3.71%
Return on Equity (ttm)
-7.60%
Revenue (ttm)
117.28k
Net Income Avi to Common (ttm)
-1.51M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
15.34k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
78.19k
Company Insights: CHHE
CHHE does not have Company Insights